UBS Group reaffirmed a “buy” rating on shares of Astrazeneca in a report on Friday, April 10th. DZ Bank upgraded Astrazeneca from a “neutral” rating to a “buy” rating in a research report on Wednesday, April 29th. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Astrazeneca in a report on Tuesday, June 30th. JPMorgan Chase & Co. reiterated a “buy” rating on shares of Astrazeneca in a research report on Tuesday, June 30th. Finally, Bank of America reissued a “buy” rating on shares of Astrazeneca in a research note on Wednesday, July 1st.